N-Acetyl Selank Amidate Spray — Research Grade Neuropeptide (10mL)
This 10mL nasal spray format of N-Acetyl Selank Amidate provides a larger volume for extended research protocols requiring intranasal delivery of the highest-potency Selank variant. N-Acetyl Selank Amidate combines N-terminal acetylation and C-terminal amidation on the tuftsin-derived heptapeptide base sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro), producing superior enzymatic stability and extended biological activity compared to unmodified Selank. HPLC verified at ≥99% purity per batch.
Research Background
Selank nasal spray closely mirrors the administration route used in published Russian clinical studies on generalized anxiety disorder and neurasthenia, where intranasal delivery was the primary protocol. The N-Acetyl Amidate modification ensures greater peptide stability in the nasal mucosa and systemic circulation relative to unmodified Selank. Research applications include anxiolytic and GABAergic modulation studies, BDNF-mediated cognitive research, tuftsin receptor immunology, and comparative neuropeptide pharmacology protocols.
Compound Specifications
- Format: Nasal spray solution
- Purity: ≥99% (HPLC verified)
- Active compound: N-Acetyl Selank Amidate
- Volume: 10mL
- Storage: 2–8°C refrigerated, protected from light
- Base sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selank)
Certificate of Analysis
Third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
